Evaluation after taking Ninjinyoeito in the treatment of post-treatment malaise associated with gynecological cancer: an prospective observational study - Evaluation after taking Ninjinyoeito in the treatment of post-treatment malaise associated with gynecological cancer: an prospective observational study

Keio University School of Medicine Center for Kampo Medicine0 个研究点目标入组 30 人开始时间: 2021年10月26日最近更新: 2023年10月17日

试验速览

暂无简介。

•1) The patients who are regularly using other Kampo medicine. 2) The patients with stage IV malignancy 3) The patients with PS(Performance Status) of 3 or 4 4) The patients considered to have a prognosis of less than six months 5) The patients with the experience an allergy after taking any Kampo medicine 6) The patients with a remarkable digestive organ symptom 7) The patients diagnosed with major depressive disorder and undergoing prescription adjustment 8) The patients with aldosteronism, myopathy, hypokalemia, or suspected 9) The patients with hepatic dysfunction (AST>80 IU/L or ALT>80 IU/L) 10) The patients who were judged not to be included by researchers

发起方

Keio University School of Medicine Center for Kampo Medicine